178 reports across 5 categories, with market size and growth to 2033.
2023–2033 CAGR · estimates
Market size in 2023
Active trials (recruiting, about to start or running)
Medtronic30 reports
Johnson & Johnson27 reports
Abbott Laboratories25 reports
Pfizer Inc.24 reports
GE Healthcare23 reports
Siemens Healthineers21 reports
Novartis AG19 reports
Philips Healthcare16 reports
Merck & Co., Inc.15 reports
Sanofi15 reports
Bayer AG15 reports
IBM Watson Health13 reports
Each market name opens its Australia report. To compare one market across every country, see market statistics.
| Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|
| Alopecia areata | – | – | – | 7 |
| Alzheimers Dignostic | $25 Mn | $57 Mn | 8.4% | 43 |
| Ambulance Service | $376 Mn | $857 Mn | 8.6% | 71 |
| Ambulatory Surgery Center | $480 Mn | $999 Mn | 7.6% | 450 |
| Antimicrobial Susceptibility Testing | – | – | – | 6 |
| Bioinformatics | $146 Mn | $640 Mn | 15.9% | – |
| Biomaterial Wound Dressing | $98 Mn | $216 Mn | 8.2% | 1 |
| Blood Gas and Electrolyte Analyzers | $34 Mn | $72 Mn | 7.9% | 8 |
| Bone Cancer Diagnostic | $13 Mn | $31 Mn | 8.9% | 67 |
| Brain Cancer Diagnostic | $18 Mn | $74 Mn | 15.1% | 81 |
| Breast Cancer Diagnostic | $49 Mn | $120 Mn | 9.3% | 195 |
| Clinical Laboratory Service | – | – | – | – |
| Dental Care Service | – | – | – | – |
| Dental Imaging | $41 Mn | $100 Mn | 9.4% | – |
| Dermatology Diagnostic | $312 Mn | $1 Bn | 12.7% | 262 |
| Fertility Service | $252 Mn | $524 Mn | 7.6% | – |
| Healthcare Electronic Data Interchange (EDI) | $48 Mn | $135 Mn | 10.9% | 3 |
| Healthcare In Vitro Diagnostic | $1 Bn | $1.7 Bn | 5.3% | 9 |
| Hospitals and Health Systems | $52.3 Bn | $103.8 Bn | 7.1% | 2,349 |
| Medical Billing | $54 Mn | $182 Mn | 12.9% | 0 |
| Medical Tourism | $890 Mn | $3.2 Bn | 13.7% | 0 |
| Nursing Education | $124 Mn | $309 Mn | 9.6% | 1 |
| Patient Support Programs (PSP) | $206 Mn | $1 Bn | 17.3% | 23 |
| Point Of Care (PoC) Molecular Diagnostic | $224 Mn | $626 Mn | 10.8% | 33 |
"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.
Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.